Sodium borohydride → HCID 13536265, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][C:9](=[O:12])[C:8]([CH2:17][CH2:18][CH2:19][N:20]3[CH2:25][CH2:24][N:23]([C:26]4[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=4)[CH2:22][CH2:21]3)([C:13]([O:15][CH3:16])=[O:14])[S:7][C:6]=2[CH:32]=1.[BH4-].[Na+]>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][CH:9]([OH:12])[C:8]([CH2:17][CH2:18][CH2:19][N:20]3[CH2:25][CH2:24][N:23]([C:26]4[CH:27]=[CH:28][CH:29]=[CH:30][CH:31]=4)[CH2:22][CH2:21]3)([C:13]([O:15][CH3:16])=[O:14])[S:7][C:6]=2[CH:32]=1Participants
3
Procedure
In the same manner as in Reference Example 12, methyl 7-chloro-3-oxo-4-[3-(4-phenylpiperazin-1-yl)propyl]-3,4-dihydro-2H-1,5-benzoxathiepine-4-carboxylate was reduced with sodium borohydride to give cis-isomer and trans-isomer of methyl 7-chloro-3-hydroxy-4-[3-(4-phenylpiperazin-1-yl)propyl]-3,4-dihydro-2H-1,5-benzoxathiepine-4-carboxylate. Trans-isomer
Sources & evidence
- ORD record
- ord-f371ad4851e8415b99d42ada6f8544a4
- Source dataset
- uspto-grants-1996_07
- Patent number
- US05538974
Reaction notes
Loading…